Inhibition of substance P signaling aggravates the bone loss in ovariectomy-induced osteoporosis

被引:17
|
作者
Zheng, Xin-Feng [1 ]
Zhao, En-Dian [1 ]
He, Ji-Ye [1 ]
Zhang, Yue-Hui [1 ]
Jiang, Sheng-Dan [1 ]
Jiang, Lei-Sheng [1 ]
机构
[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Orthopaed Surg, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China
来源
关键词
Osteoporosis; Substance P; NK1; receptor; Bone remodeling; Ovariectomy; VASOACTIVE-INTESTINAL-PEPTIDE; RECEPTOR NK1 ANTAGONIST; GENE-RELATED PEPTIDE; SPINAL-CORD-INJURY; NEUROKININ-1; RECEPTOR; REPRODUCTIVE FUNCTION; PARATHYROID-HORMONE; ESTROGEN; CELLS; RAT;
D O I
10.1016/j.pbiomolbio.2016.05.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: Substance P signaling regulates the functions of both osteoblast and osteoclast. Available reports on the effects of substance P on bone mass are contradictory. The objective of this study was to determine the change of substance P expression in the osteoporotic bone of OVX mice. The effects of substance P signaling blockade by using its specific receptor antagonist L-703606 on bone remodeling in sham-operated mice and OVX mice were also investigated. Methods: Forty-eight nine-week-old female C57BL/6J mice were evenly distributed into three groups with sham surgery, OVX or OVX with estrogen replacement. Substance P expression in the bones of each group of mice was evaluated by immunohistochemistry and enzyme immunoassay. Another thirty-two nine-week-old female C57BL/6J mice were divided into a SHAM group (sham surgery followed by vehicle treatment with DMSO), a SHAM + L group (sham surgery followed by 15 mg/kg/d L-703606 repeated intraperitoneal injections), an OVX group (ovariectomy with the same vehicle treatment) and an OVX + L group (ovariectomy with the same L-703606 injections), with 8 mice in each group. Treatment started 3 weeks after surgery and last for 3 weeks. A 2 x 2 factorial experimental design was used to detect the effects of substance P signaling blockade on bone remodeling in sham-operated mice and OVX mice. Techniques including micro-computed tomography, biomechanical testing, histomorphometric analysis, enzyme immunoassay, and real-time PCR were employed. Results: Immunohistochemistry and enzyme immunoassay revealed that substance P expression significantly decreased in the bones of OVX mice both at 3 weeks and 6 weeks after surgery. Micro-CT tomography demonstrated that application of L-703606 led to bone loss in sham-operated mice, and aggravated the micro-structural deterioration of bones in OVX mice. This was shown by reduced BV/TV (Mean bone volume fraction), Tb.N (Mean trabecular number) and Tb.Th (Mean trabecular thickness), and increased Tb.Sp (Mean trabecular separation). Biomechanical analysis demonstrated that blockade of substance P signaling reduced the maximum stress and maximum load of L3 vertebrae and tibiae. Inhibited recruitment of bone mesenchymal stem cells (BMSCs) to bone remodeling sites, which was evidenced by increased number of osteoclasts, decreased number of osteoblasts and increased osteoid volume in the secondary spongiosa, was observed in the mice treated with L-703606. A significant decrease of OPG/RANKL ratio was also found in the bones of mice treated with L-703606. Body weight, uterine weight and serum estradiol level were not significantly different between the mice treated with L-703606 and those treated with vehicle. Conclusion: The results demonstrated that blocking substance P signaling led to bone loss in sham operated mice, and exacerbated the bone loss in OVX mice. Substance P signaling had an important role in the maintenance of bone mass. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:112 / 121
页数:10
相关论文
共 50 条
  • [31] MECHANICAL LOADING MODIFIES OVARIECTOMY-INDUCED CANCELLOUS BONE LOSS
    LIN, BY
    JEE, WSS
    CHEN, MM
    MA, YF
    KE, HZ
    LI, XJ
    BONE AND MINERAL, 1994, 25 (03): : 199 - 210
  • [32] Protective Effect of Acteoside on Ovariectomy-Induced Bone Loss in Mice
    Yang, Lingling
    Zhang, Bo
    Liu, Jingjing
    Dong, Yanhong
    Li, Yanting
    Li, Nan
    Zhao, Xiaojun
    Snooks, Hunter
    Hu, Changling
    Ma, Xueqin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (12):
  • [33] Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss
    Zhang, Yong
    Guan, Hanfeng
    Li, Jing
    Fang, Zhong
    Chen, Wenjian
    Li, Feng
    SCIENTIFIC REPORTS, 2015, 5
  • [34] Ovariectomy-induced bone loss occurs independently of B cells
    Li, Yan
    Li, Aimin
    Yang, Xiaoying
    Weitzmann, M. Neale
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 100 (06) : 1370 - 1375
  • [35] Cilostazol Attenuates Ovariectomy-Induced Bone Loss by Inhibiting Osteoclastogenesis
    Ke, Ke
    Safder, Ali Muhammad
    Sul, Ok-Joo
    Suh, Jae-Hee
    Joe, Yeonsoo
    Chung, Hun-Taeg
    Choi, Hye-Seon
    PLOS ONE, 2015, 10 (05):
  • [36] Nitric oxide donor alleviates ovariectomy-induced bone loss
    Wimalawansa, SJ
    DeMarco, G
    Gangula, P
    Yallampalli, C
    BONE, 1996, 18 (04) : 301 - 304
  • [37] Effect of lignans on ovariectomy-induced bone loss in rats.
    Horcajada-Molteni, M
    Davicco, M
    Lebecque, P
    Coxam, V
    Miller, S
    Rémésy, C
    Barlet, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S553 - S553
  • [38] Protective effect of apigenin on ovariectomy-induced bone loss in rats
    Park, Jeong A.
    Ha, Sang Keun
    Kang, Tong Ho
    Oh, Myung Sook
    Cho, Min Hyoung
    Lee, Soo Yeol
    Park, Ji-Ho
    Kim, Sun Yeou
    LIFE SCIENCES, 2008, 82 (25-26) : 1217 - 1223
  • [39] Activation of NF-κB signaling regulates ovariectomy-induced bone loss and weight gain
    Huang, Fei
    Gao, Jing
    Li, Aonan
    Mizokami, Akiko
    Matsuda, Miho
    Aoki, Kazuhiro
    Katagiri, Takenobu
    Kawakubo-Yasukochi, Tomoyo
    Jimi, Eijiro
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (07):
  • [40] Lack of NOD2 attenuates ovariectomy-induced bone loss via inhibition of osteoclasts
    Ke, Ke
    Sul, Ok-Joo
    Chung, Soo-Wol
    Suh, Jae-Hee
    Choi, Hye-Seon
    JOURNAL OF ENDOCRINOLOGY, 2017, 235 (02) : 85 - 96